Embryonic Hyperglycemia Disrupts Myocardial Growth, Morphological Development, and Cellular Organization: An In Vivo Experimental Study

Hyperglycemia during gestation can disrupt fetal heart development and increase postnatal cardiovascular disease risk. It is therefore imperative to identify early biomarkers of hyperglycemia during gestation-induced fetal heart damage and elucidate the underlying molecular pathomechanisms. Clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaime-Cruz, Ricardo, Sánchez-Gómez, Concepción, Villavicencio-Guzmán, Laura, Lazzarini-Lechuga, Roberto, Patiño-Morales, Carlos César, García-Lorenzana, Mario, Ramírez-Fuentes, Tania Cristina, Salazar-García, Marcela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056749/
https://www.ncbi.nlm.nih.gov/pubmed/36983924
http://dx.doi.org/10.3390/life13030768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056749/
https://www.ncbi.nlm.nih.gov/pubmed/36983924
http://dx.doi.org/10.3390/life13030768

Ejemplares similares